[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:c-peptide":3},{"name":4,"total":5,"recruiting":6,"trials":7},"C Peptide",28,20,[8,16,23,29,35,41,47,54,60,67,73,79,85,91,97,103,109,115,121,127,133,140,146,152,158,165,172,178],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07592000","Breakthrough - T1DM and Chronic Kidney Disease",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:15:01.639696Z","2026-05-29T15:36:40.202906Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07568678","A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes",[20],"Phase 1","2026-08-26T02:18:12.612955Z","2026-05-13T02:55:06.732617Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07061574","A Randomized Phase 1\u002F2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes",[12],"2026-08-26T02:16:44.178623Z","2026-05-05T02:43:28.984675Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT05626712","Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes",[12],"2026-08-26T02:19:07.104270Z","2026-05-05T02:43:28.809043Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07341373","A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500",[20],"2026-08-26T02:17:11.311767Z","2026-05-05T02:43:28.630588Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT06783309","CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)",[12],"2026-08-26T02:18:11.042248Z","2026-05-05T02:43:28.627427Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":52,"content_modified":53},"NCT07088068","A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes",[51],"Phase 3","2026-08-26T02:16:32.589113Z","2026-05-05T02:43:28.185741Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT07222332","A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)",[51],"2026-08-26T02:19:12.219640Z","2026-05-05T02:43:27.912974Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":65,"content_modified":66},"NCT01241864","Islet Transplantation in Type 1 Diabetic Kidney Allograft",[64],"Phase 2","2026-08-26T02:15:10.362237Z","2026-05-05T02:43:27.488438Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT01630850","Islet Transplantation in Patients With \"Brittle\" Type I Diabetes",[],"2026-08-26T02:15:41.377360Z","2026-05-05T02:43:26.975606Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT06919354","A Study of GNTI-122 in Adults Recently Diagnosed With T1D",[20],"2026-08-26T02:19:19.975067Z","2026-05-05T02:43:26.750802Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT04101669","RESET System Pivotal Trial (Rev F)",[],"2026-08-26T02:15:59.318403Z","2026-05-05T02:43:26.686788Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT06575426","A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus",[12],"2026-08-26T02:19:13.549512Z","2026-05-05T02:35:31.899244Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT06305286","Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)",[12],"2026-08-03T03:49:37.452409Z","2026-04-29T02:57:57.154309Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT07142252","Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus",[64],"2026-08-26T02:16:38.897933Z","2026-04-29T02:57:57.116913Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT06524960","Denosumab for Type 1 Diabetes",[12],"2026-08-26T02:18:57.189473Z","2026-04-29T02:57:57.064031Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT01999361","Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss",[],"2026-08-26T02:16:58.658552Z","2026-05-05T02:43:27.832068Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT05237934","Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)",[],"2026-08-26T02:15:45.413021Z","2026-05-13T02:55:06.298667Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT04334707","Kidney Precision Medicine Project",[],"2026-08-26T02:17:42.501124Z","2026-05-13T02:55:06.249030Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT07187531","SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes",[64],"2026-08-26T02:18:26.932189Z","2026-05-05T02:43:29.491704Z",{"nct_id":134,"title":135,"phases":136,"status":137,"updated_at":138,"content_modified":139},"NCT07257068","Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study",[],"NOT_YET_RECRUITING","2026-08-26T02:15:11.740957Z","2026-05-05T02:43:29.468497Z",{"nct_id":141,"title":142,"phases":143,"status":137,"updated_at":21,"content_modified":145},"NCT07395050","Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes",[144],"Early Phase 1","2026-05-05T02:43:29.398262Z",{"nct_id":147,"title":148,"phases":149,"status":137,"updated_at":150,"content_modified":151},"NCT05453851","A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors",[12],"2026-08-26T02:19:15.498463Z","2026-05-05T02:43:28.020934Z",{"nct_id":153,"title":154,"phases":155,"status":137,"updated_at":156,"content_modified":157},"NCT07616206","Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems",[64],"2026-08-26T02:16:51.982021Z","2026-06-02T11:21:24.699004Z",{"nct_id":159,"title":160,"phases":161,"status":162,"updated_at":163,"content_modified":164},"NCT05973734","Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy",[20],"ENROLLING_BY_INVITATION","2026-08-26T02:17:30.961790Z","2026-05-05T02:43:28.113172Z",{"nct_id":166,"title":167,"phases":168,"status":169,"updated_at":170,"content_modified":171},"NCT06111586","FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)",[64],"ACTIVE_NOT_RECRUITING","2026-08-03T02:11:04.414058Z","2026-05-05T02:43:29.482368Z",{"nct_id":173,"title":174,"phases":175,"status":169,"updated_at":176,"content_modified":177},"NCT05180591","Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes",[64],"2026-08-03T02:59:27.405045Z","2026-05-05T02:43:28.847008Z",{"nct_id":179,"title":180,"phases":181,"status":169,"updated_at":183,"content_modified":184},"NCT03878459","Dapagliflozin Plus Pioglitazone in T1DM",[182],"Phase 4","2026-08-03T03:19:09.261668Z","2026-05-05T02:43:27.632134Z"]